Manufacturing medicines in Australia: examining the need for increased domestic capability

Against an international backdrop this article discusses the identified supply chain risks and considers whether such an initiative is commercially feasible in the absence of significant government investment and intervention. It also looks at two key initiatives already in place designed to help mitigate the risk of medicine supply chain shortages.